CN102512474B - Ointment for treating nasal polyp - Google Patents
Ointment for treating nasal polyp Download PDFInfo
- Publication number
- CN102512474B CN102512474B CN2011104365167A CN201110436516A CN102512474B CN 102512474 B CN102512474 B CN 102512474B CN 2011104365167 A CN2011104365167 A CN 2011104365167A CN 201110436516 A CN201110436516 A CN 201110436516A CN 102512474 B CN102512474 B CN 102512474B
- Authority
- CN
- China
- Prior art keywords
- artificial
- ointment
- vaseline
- scorpio
- herba centipedae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 18
- 208000000592 Nasal Polyps Diseases 0.000 title abstract description 11
- 229940099259 Vaseline Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 7
- 241000972155 Moschus Species 0.000 claims description 10
- 241000522620 Scorpio Species 0.000 claims description 10
- 239000009490 scorpio Substances 0.000 claims description 10
- 239000000470 constituent Substances 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 83.4,218.0 L 114.0,181.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 114.0,181.0 L 97.2,136.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 120.4,171.0 L 108.7,139.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-16 atom-1' d='M 161.2,189.0 L 114.0,181.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 97.2,136.1 L 85.7,134.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 85.7,134.2 L 74.2,132.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-2 atom-6' d='M 97.2,136.1 L 127.8,99.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 44.0,112.2 L 42.2,107.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 42.2,107.4 L 40.4,102.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 33.2,140.9 L 30.2,144.5' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 30.2,144.5 L 27.1,148.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 40.6,147.0 L 37.6,150.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 37.6,150.6 L 34.5,154.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 127.8,99.1 L 175.1,107.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 133.3,109.8 L 166.4,115.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 175.1,107.1 L 183.8,96.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 183.8,96.6 L 192.6,86.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-7 atom-11' d='M 175.1,107.1 L 191.8,152.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 199.7,54.2 L 197.9,49.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 197.9,49.4 L 196.1,44.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 229.1,79.0 L 232.7,79.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 232.7,79.6 L 236.3,80.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 230.7,69.5 L 234.3,70.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 234.3,70.2 L 237.9,70.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 191.8,152.1 L 239.1,160.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-11 atom-16' d='M 191.8,152.1 L 161.2,189.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-11 atom-16' d='M 179.8,151.5 L 158.4,177.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 239.1,160.1 L 231.1,207.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-12 atom-14' d='M 239.1,160.1 L 247.1,112.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-12 atom-15' d='M 239.1,160.1 L 286.4,168.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 161.2,189.0 L 166.6,203.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 166.6,203.5 L 172.0,218.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 164.9,249.8 L 161.9,253.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 161.9,253.4 L 158.8,257.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 201.4,242.8 L 205.1,243.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 205.1,243.4 L 208.7,244.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 203.0,233.3 L 206.7,234.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 206.7,234.0 L 210.3,234.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='44.2' y='137.7' class='atom-3' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='57.4' y='130.0' class='atom-3' style='font-size:12px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='27.5' y='92.8' class='atom-4' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='40.7' y='85.1' class='atom-4' style='font-size:12px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='13.6' y='174.7' class='atom-5' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='199.9' y='79.8' class='atom-8' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='213.1' y='72.1' class='atom-8' style='font-size:12px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='183.1' y='34.8' class='atom-9' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='196.4' y='27.2' class='atom-9' style='font-size:12px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='247.2' y='87.8' class='atom-10' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='172.2' y='243.6' class='atom-17' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='185.4' y='235.9' class='atom-17' style='font-size:12px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='141.7' y='280.5' class='atom-18' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='154.9' y='272.8' class='atom-18' style='font-size:12px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='219.5' y='251.5' class='atom-19' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 23.1,61.3 L 31.8,50.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 31.8,50.8 L 27.1,38.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 33.6,47.9 L 30.3,39.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-16 atom-1' d='M 45.2,53.1 L 31.8,50.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 27.1,38.1 L 22.7,37.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 22.7,37.3 L 18.3,36.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-2 atom-6' d='M 27.1,38.1 L 35.7,27.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 12.9,33.7 L 11.5,30.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 11.5,30.0 L 10.1,26.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 10.5,37.5 L 8.1,40.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 8.1,40.4 L 5.7,43.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 12.6,39.3 L 10.2,42.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 10.2,42.2 L 7.7,45.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 35.7,27.6 L 49.1,29.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 37.3,30.6 L 46.6,32.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 49.1,29.9 L 52.4,25.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 52.4,25.9 L 55.6,22.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-7 atom-11' d='M 49.1,29.9 L 53.8,42.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 57.0,17.2 L 55.6,13.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 55.6,13.6 L 54.2,9.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 62.1,21.5 L 65.5,22.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 65.5,22.1 L 68.9,22.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 62.6,18.8 L 66.0,19.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 66.0,19.4 L 69.4,20.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 53.8,42.6 L 67.2,44.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-11 atom-16' d='M 53.8,42.6 L 45.2,53.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-11 atom-16' d='M 50.5,42.4 L 44.4,49.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 67.2,44.8 L 65.0,58.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-12 atom-14' d='M 67.2,44.8 L 69.5,31.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-12 atom-15' d='M 67.2,44.8 L 80.6,47.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 45.2,53.1 L 47.2,58.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 47.2,58.4 L 49.1,63.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 47.8,68.4 L 45.4,71.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 45.4,71.3 L 43.0,74.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 54.3,67.9 L 57.7,68.5' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 57.7,68.5 L 61.1,69.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 54.8,65.2 L 58.1,65.8' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 58.1,65.8 L 61.5,66.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='11.9' y='38.8' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='16.0' y='36.4' class='atom-3' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='7.1' y='26.1' class='atom-4' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='11.3' y='23.7' class='atom-4' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='3.2' y='49.3' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='56.0' y='22.4' class='atom-8' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='60.1' y='20.0' class='atom-8' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='51.2' y='9.7' class='atom-9' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='55.4' y='7.3' class='atom-9' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='69.4' y='24.6' class='atom-10' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='48.1' y='68.8' class='atom-17' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='52.3' y='66.4' class='atom-17' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='39.5' y='79.3' class='atom-18' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='43.6' y='76.9' class='atom-18' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='61.5' y='71.1' class='atom-19' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 abstract 3
- 206010004542 Bezoar Diseases 0.000 abstract 3
- 241000239226 Scorpiones Species 0.000 abstract 3
- 241000245665 Taraxacum Species 0.000 abstract 3
- 235000009242 dandelion Nutrition 0.000 abstract 3
- 235000014079 dandelion Nutrition 0.000 abstract 3
- 238000001816 cooling Methods 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 210000001331 Nose Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000001736 Capillaries Anatomy 0.000 description 2
- 206010050515 Hyposmia Diseases 0.000 description 2
- 235000019559 hyposmia Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 1
- 241000565118 Cordylophora caspia Species 0.000 description 1
- 208000002173 Dizziness Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000001705 Mouth Breathing Diseases 0.000 description 1
- 210000003097 Mucus Anatomy 0.000 description 1
- 210000003928 Nasal Cavity Anatomy 0.000 description 1
- 210000002850 Nasal Mucosa Anatomy 0.000 description 1
- 210000001989 Nasopharynx Anatomy 0.000 description 1
- 206010061529 Polyp Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 201000007100 pharyngitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Abstract
The present invention discloses an ointment for treating nasal polyp. The ointment comprises the following components: 0.05-0.15g artificial bezoar, 0.05-0.15g artificial musk, 0.1-0.5g scorpion, 0.25-0.75g Herba Centipedae, 0.1-0.5g dry dandelion, 0.2g cooling oil and 0.5g vaseline. a production process comprises the following steps: crushing artificial bezoar, artificial musk, scorpion, Herba Centipedae and dry dandelion into fine powder capable of passing through a sieve with 270 meshes, then taking artificial bezoar, artificial musk, scorpion, Herba Centipedae and dry dandelion with the above ratio, and finally adding cooling oil and vaseline with the proportion, uniformly mixing and packaging. The ointment for treating nasal polyp has the advantages of easy usage, and no toxic and side effect, and the clinical tests of 500 patients show that the cure rate is 100%.
Description
Technical field
The present invention relates to a kind of ointment, especially a kind of polypous ointment.
Background technology
Nasal polyp is the smooth surface in the nose key, translucent, softness touched and bitterly vegetation not, and this vegetation is hindered breath, shows as persistence and has a stuffy nose.The nasal obstruction reason is because nasal cavity blood capillary circulation is not smooth, causes capillary dilation and causes, uses the vasoconstrictor collunarium without obvious curative effects, the patient also can cause hyposmia because of nasal obstruction, closed rhinolalia, sleep snoring and mouth breathing, but secondary chronic pharyngitis of a specified duration.Nasal polyp is early stage, and patient's intranasal seemingly has the nasal mucus of can not blowing, and mostly is serosity, if accompanying infection can have purulent secretion.The patient is sneeze seldom, if but nasal mucosa has allergic inflammation, and also can sneeze.If in time do not find the state of an illness, nasal polyp can continue to increase, and nasal obstruction is obviously increased the weight of, and can cause headache or dizzy, hyposmia so that disappearance.If polyp blocks choana, even charge into nasopharynx part, can cause auditory dysesthesia, also can cause bridge of the nose broadening, form in " frog nose ".
At present, treating polypous main method is operative treatment, utilizes operative treatment to have certain risk.Therefore, the polypous ointment for the treatment of of a kind of external of research is the present technical issues that need to address.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of polypous ointment for the treatment of.
The technical scheme that the present invention solves its technical problem is:
a kind ofly treat polypous ointment, its constituent is: artificial Calculus Bovis 0.05～0.15g, artificial Moschus 0.05～0.15g, Scorpio 0.1～0.5g, Herba Centipedae 0.25～0.75g, dried Herba Taraxaci 0.1～0.5g, menthocamphorate 0.2g, vaseline 0.5g, its processing technology is: at first with the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci pulverizes into and can pass through 270 eye mesh screen fine powders, then measure according to the above ratio the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci powder, add in proportion at last menthocamphorate and vaseline, mixing well pack gets final product.
The optimal technical scheme that the present invention solves its technical problem is:
Its constituent is: artificial Calculus Bovis 0.1g, artificial Moschus 0.1g, Scorpio 0.3g, Herba Centipedae 0.5g, dried Herba Taraxaci 0.3g, menthocamphorate 0.2g, vaseline 0.5g.
Therapeutic Method:
With ointment obliterating of the present invention affected part, every day, each once, can fully recover in 30～35 days sooner or later.
Compared with prior art, the present invention is easy to use, has no side effect, through 500 routine patient clinicals, cure rate 100%.
Illustrate therapeutic effect of the present invention below by several model cases:
Case one, the field so-and-so, the man, 23 years old, area just outside a city gate town, Quzhou County, Hebei people from North Street suffered from nasal polyp.Adopt medicinal ointment therapy of the present invention, recovery from illness on the 3rd was not recurred after recovery from illness.
Case two, Zhao so-and-so, the female, 33 years old, western fort people opened in Yongnian County, Hebei, suffered from nasal polyp, adopted medicinal ointment therapy of the present invention, fully recovered in 3rd.
Case three, Lee so-and-so, the man, 24 years old, beam tube people from town, Daming County, Hebei suffered from nasal polyp, adopts medicinal ointment therapy of the present invention, recovery from illness on the 3rd is recurred for many years.
Case four, military so-and-so, the female, 17 years old, Handan City's Congtai District was suffered from nasal polyp, adopts medicinal ointment therapy of the present invention, fully recovered in 3rd.
Case five, Hao so-and-so, the female, 20 years old, the Hanshan District people of Handan City suffered from nasal polyp, adopts medicinal ointment therapy of the present invention, fully recovered in 3rd.
The specific embodiment
Enumerate 10 specific embodiments of the present invention below by the mode of list; whole compositions are market and directly buy; its processing technology is: at first artificial Calculus Bovis, artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci are pulverized into and can pass through 270 eye mesh screen fine powders; then measure according to the above ratio artificial Calculus Bovis, artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci powder; add in proportion at last menthocamphorate and vaseline, mix well pack and get final product.
Unit: g
Claims (2)
1. treat polypous ointment for one kind, it is characterized in that: its constituent is: artificial Calculus Bovis 0.05～0.15g, artificial Moschus 0.05～0.15g, Scorpio 0.1～0.5g, Herba Centipedae 0.25～0.75g, dried Herba Taraxaci 0.1～0.5g, menthocamphorate 0.2g, vaseline 0.5g, its processing technology is: at first with the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci pulverizes into and can pass through 270 eye mesh screen fine powders, then measure according to the above ratio the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci powder, add in proportion at last menthocamphorate and vaseline, mixing well pack gets final product.
2. a kind of polypous ointment for the treatment of according to claim 1, it is characterized in that: its constituent is: artificial Calculus Bovis 0.1g, artificial Moschus 0.1g, Scorpio 0.3g, Herba Centipedae 0.5g, dried Herba Taraxaci 0.3g, menthocamphorate 0.2g, vaseline 0.5g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104365167A CN102512474B (en) | 2011-12-23 | 2011-12-23 | Ointment for treating nasal polyp |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104365167A CN102512474B (en) | 2011-12-23 | 2011-12-23 | Ointment for treating nasal polyp |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512474A CN102512474A (en) | 2012-06-27 |
| CN102512474B true CN102512474B (en) | 2013-06-26 |
Family
ID=46283727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104365167A Expired - Fee Related CN102512474B (en) | 2011-12-23 | 2011-12-23 | Ointment for treating nasal polyp |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512474B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772539B (en) * | 2012-07-31 | 2016-02-17 | 富阳原野生物科技有限公司 | A kind of tincture dose medicament for the treatment of asthenic cold type nasal polyp |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1295850A (en) * | 1999-11-15 | 2001-05-23 | 许其宽 | Bitongling mixture injection for curing nasal obstruction |
| CN102247438A (en) * | 2010-05-18 | 2011-11-23 | 马赛香 | Medicine for dredging nasal orifice through application method of sniffing |
-
2011
- 2011-12-23 CN CN2011104365167A patent/CN102512474B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1295850A (en) * | 1999-11-15 | 2001-05-23 | 许其宽 | Bitongling mixture injection for curing nasal obstruction |
| CN102247438A (en) * | 2010-05-18 | 2011-11-23 | 马赛香 | Medicine for dredging nasal orifice through application method of sniffing |
Non-Patent Citations (10)
| Title |
|---|
| 中西医结合治疗慢性鼻窦炎鼻息肉;陈国春;《福建中医学院学报》;20050810;第15卷(第04期);全文 * |
| 中西医结合治疗慢性鼻窦炎鼻息肉;陈萍等;《上海中医药杂志》;20060415;第40卷(第04期);全文 * |
| 中西医结合治疗慢性鼻窦炎鼻息肉54例;周文茹等;《江苏中医药》;20040110;第24卷(第12期);全文 * |
| 周文茹等.中西医结合治疗慢性鼻窦炎鼻息肉54例.《江苏中医药》.2004,第24卷(第12期),全文. |
| 慢性上颌窦炎的临床研究近况;肖辉良;《江西中医药》;19960421;第27卷(第02期);全文 * |
| 李文波等.治鼻息肉方.《中国民间疗法》.2003,第11卷(第06期),全文. |
| 治鼻息肉方;李文波等;《中国民间疗法》;20030628;第11卷(第06期);全文 * |
| 肖辉良.慢性上颌窦炎的临床研究近况.《江西中医药》.1996,第27卷(第02期),全文. |
| 陈国春.中西医结合治疗慢性鼻窦炎鼻息肉.《福建中医学院学报》.2005,第15卷(第04期),全文. |
| 陈萍等.中西医结合治疗慢性鼻窦炎鼻息肉.《上海中医药杂志》.2006,第40卷(第04期),全文. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512474A (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103142785B (en) | Rhinitis treatment medicine | |
| CN103623267B (en) | Medication for treating allergic rhinitis | |
| CN103566344B (en) | Blood-invigorating and muscles and joints-relaxing paste | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN102512474B (en) | Ointment for treating nasal polyp | |
| CN103316086B (en) | Tibetan medicine for treating influenza and preparation method thereof | |
| CN101019906A (en) | Chinese medicine for relieving cough, eliminating phlegm and relieving asthma | |
| CN103142857B (en) | Chinese medicinal granules for treating bronchitis combined emphysema and preparation method thereof | |
| CN103356988B (en) | Traditional Chinese medicine preparation for treating bronchus asthma of children | |
| CN104940288A (en) | Medicine for treating common-cold fever and headache | |
| CN102512462A (en) | Ointment for treating rhinitis | |
| CN107929366A (en) | A kind of Chinese medicine composition for treating allergic rhinitis | |
| CN103638189B (en) | The Chinese medicine preparation for the treatment of acute pharyngitis | |
| CN102151224B (en) | Infantile cerebral palsy acupuncture point heat treatment plaster | |
| CN102940873B (en) | Externally used medicine composition for treating sprains and preparation method thereof | |
| CN105582376A (en) | Externally-used traditional Chinese medicine for treating rubella | |
| CN102755607B (en) | Medicine for treating bronchitis and asthma and preparation method thereof | |
| CN105125880A (en) | Traditional Chinese medicine for treating chronic tonsillitis | |
| CN105169009A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating viral influenza | |
| CN105213615A (en) | Compound Solanum Nigrum Pianomide | |
| WO2016078152A1 (en) | Chill-dispelling traditional chinese medicine | |
| CN104042905A (en) | Traditional Chinese medicine for treating nasosinusitis | |
| CN102512478B (en) | Chronic pharyngitis oral liquid | |
| CN107496740A (en) | A kind of pill medicine for treating children's abundant expectoration cough and asthma and preparation method thereof | |
| CN104940336A (en) | Medicine for treating cough due to pathogenic wind-cold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130626 Termination date: 20131223 |